Correction: Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition.
[This corrects the article DOI: 10.1371/journal.pone.0181082.].
Main Authors: | Andreas Austgulen Westin, Malin Brekke, Espen Molden, Eirik Skogvoll, Olav Spigset |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5770058?pdf=render |
Similar Items
-
Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition.
by: Andreas Austgulen Westin, et al.
Published: (2017-01-01) -
Pharmacovigilance of serotonin reuptake inhibitors
by: Darpan Kaur, et al.
Published: (2013-01-01) -
Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
by: Chad Compagner, et al.
Published: (2021-01-01) -
Selective Serotonin Reuptake Inhibitors in Human Pregnancy: To Treat or Not to Treat?
by: Orna Diav-Citrin, et al.
Published: (2012-01-01) -
Differential Potency of Venlafaxine, Paroxetine, and Atomoxetine to Inhibit Serotonin and Norepinephrine Reuptake in Patients With Major Depressive Disorder
by: Aldosary, F., et al.
Published: (2022)